Results 41 to 50 of about 5,988 (201)

Safety and Efficacy of DOACs in Patients with Advanced and End-Stage Renal Disease

, 2022
The prevalence of chronic kidney disease (CKD) is increasing due to the aging of the population and multiplication of risk factors, such as hypertension, arteriosclerosis and obesity.
Aleksandra Gąsecka, Krzysztof J. Filipiak, Sylwester Rogula, Łukasz Szarpak, Tomasz Mazurek, Eliano Pio Navarese   +5 more
core   +1 more source

Comparing outcomes using low‐dose apixaban and anti‐Xa monitoring and vitamin K antagonists in patients with renal replacement therapy

British Journal of Clinical Pharmacology, EarlyView.
Background Guidelines recommend oral anticoagulation for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism. Outside the United States, apixaban is unlicensed for use in patients with end‐stage renal disease (ESRD) receiving renal replacement therapy (RRT).
John K. Bartoli‐Abdou, Alexander T. Cohen, Lucy Vernon, Victoria Collings, Ubonphan Chaichana, Natasha Moore, Hamda Jibril, Li Wei, Nicola Kumar, Karen A. Breen, Andrew J. Doyle   +10 more
wiley   +1 more source

Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!

The Egyptian Heart Journal, 2022
Oral vitamin K antagonists (VKAs), warfarin, have been in routine clinical use for almost 70 years for various cardiovascular conditions. Direct-Acting Oral Anticoagulants (DOACs) have emerged as competitive alternatives for VKAs to prevent stroke in ...
Mahmoud Abdelnabi, Juthipong Benjanuwattra, Osama Okasha, Abdallah Almaghraby, Yehia Saleh, Fady Gerges   +5 more
doaj   +1 more source

DOACs in Patients With Giant Coronary Artery Aneurysms After Kawasaki Disease [PDF]

, 2023
This case series examines outcomes among patients with giant coronary artery aneurysms after Kawasaki disease treated with direct oral anticoagulants (DOACs)
Burns, Jane C, Dummer, Kirsten B, Gleason, Jill, Shimizu, Chisato, Gordon, John B, Tremoulet, Adriana H, Miyata, Koichi   +6 more
core   +1 more source

Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS)

Advances in Rheumatology, 2020
Background The term Direct Oral Anticoagulants (DOACs) refers to a group of drugs that inhibit factor Xa or thrombin. Even though their use for treating different thrombotic or prothrombotic conditions is increasing recently, there is no compelling ...
Gustavo Guimarães Moreira Balbi, Marcelo de Souza Pacheco, Odirlei Andre Monticielo, Andreas Funke, Adriana Danowski, Mittermayer Barreto Santiago, Henrique Luiz Staub, Jozelia Rêgo, Danieli Castro Oliveira de Andrade   +8 more
doaj   +1 more source

[Contraindications to DOACs in atrial fibrillation].

Nederlands tijdschrift voor geneeskunde, 2020
Sometimes there is doubt as to whether or not anticoagulants should be initiated, and if so which ones, in patients with atrial fibrillation and advanced age, increased frailty, or fall risk, kidney, or liver impairment, alcohol abuse, uncontrolled hypertension, or a history of major bleeding.
Vries, T.A.C. de, Hemels, M.E.W., Pisters, R., Jansen, R., Groot, J.R. de   +4 more
openaire   +3 more sources

DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in Circulation

Thrombosis and Haemostasis, 2022
AbstractIn certain clinical situations, it is necessary to determine whether clinically relevant plasma levels of direct oral anticoagulants (DOACs) are present. We examined whether qualitative testing of DOACs in urine samples can exclude DOAC plasma concentrations of ≥30 ng/mL. This prospective single-center cohort study included consecutive patients
Margetić, Sandra, Ćelap, Ivana, Lovrenčić Huzjan, Arijana, Bosnar Puretić, Marijana, Šupraha Goreta, Sandra, Glojnarić, Anesa Čajević, Delić Brkljačić, Diana, Mioč, Pavao, Harenberg, Job, Hetjens, Svetlana, Weiss, Christel   +10 more
openaire   +2 more sources

Temporal Trends and Prognosis in Rotational Atherectomy: A Comparison of Contemporary and Traditional Eras

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Rotational atherectomy (RA) has undergone considerable technical modernization in recent years. This study evaluated whether RA performed in the contemporary era was associated with superior cardiovascular outcomes compared with the traditional era. Aims To compare the clinical characteristics and cardiovascular outcomes of patients
Ravi Vazirani, Gonzalo García‐Martí, Andrés Provencio‐Regidor, Irene Serrano‐García, Adrián Jerónimo‐Baza, Alejandro Travieso, Gabriela Tirado‐Conte, Fernando Macaya‐Ten, Hernán Mejía‐Rentería, Pablo Salinas, Luis Nombela‐Franco, Pilar Jiménez‐Quevedo, Nieves Gonzalo, Javier Escaned, Antonio Fernández‐Ortiz, Iván J. Núñez‐Gil   +15 more
wiley   +1 more source

Can DOACs protect patients with AF from dementia?

, 2022
https://insightplus.mja.com.au/2022/16/can-doacs-protect-patients-with-af-from ...
Woldesellassie Bezabhe (14731726), Janette Radford (14747401), Gregory Peterson (14746654)   +2 more
core  

Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation

BMC Cardiovascular Disorders, 2018
Background Atrial fibrillation (AF) is common in patients with heart failure and is associated with higher mortality. Although previous studies have reported that direct oral anticoagulants (DOACs) reduce the risk of cardiovascular events in out-patients
Akiomi Yoshihisa, Yu Sato, Takamasa Sato, Satoshi Suzuki, Masayoshi Oikawa, Yasuchika Takeishi   +5 more
doaj   +1 more source